UNSPSC 51343309: Viroxime

This classification denotes an antiviral agent with the molecular formula (C17H18N4O3S)2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I5V34WG2BE, more generally known as viroxime. European Medicines Agency schedules viroxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00082MIG. The term VIROXIME is an International Non-Proprietary Name or INN. VIROXIME is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule viroxime under HS 29350090 and SITC 51580. As of Q4 2014, VIROXIME remains the US FDA Preferred Term for this commodity. SMILES: CC(C)S(=O)(=O)N1C2=C(C=CC(=C2)C(=NO)C3=CC=CC=C3)N=C1N.

UNSPSC 51343309 Viroxime is a Commodity code that does not align with the work state and local governments are actually buying under this classification. The recent opportunities posted under this code involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals and over-the-counter products—none of which are viroxime-specific procurements. The code appears to represent a single antiviral drug product, yet the actual solicitations reflect broad pharmaceutical procurement, emergency medical supplies, and pharmacy benefit program initiatives that fall outside viroxime's scope.

The issuing bodies are diverse and include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire departments (City of Tampa), and interstate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). The geographic spread spans Florida, Texas, and Minnesota, with cooperative purchasing mechanisms extending to Oregon. Representative recent opportunities include Seminole County's IFB60459723LAS for naloxone and drug deactivation systems with an IFB notice and July 26, 2023 response deadline (annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems); the City of Tampa's Bid 26P00145 for medical and first aid supplies supporting the Fire Department Rescue Division, posted March 25, 2026 with a March 13, 2026 response deadline and a $700,000 estimated contract amount, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent SLBE bid discount; and MMCAP's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products, posted January 20, 2026 with a March 26, 2026 response deadline. The mismatch between the code name and actual procurement activity suggests limited or misclassified opportunities under this specific commodity code.